Pernas B, Iacoboni G, Los-Arcos I, Carpio C, et al. Patients with aggressive B-cell lymphoma receiving CAR T-cell therapy have a low rate of severe infections despite lack of universal antibacterial and antifungal prophylaxis. Eur J Haematol 2024 Apr 26. doi: 10.1111/ejh.14207.
PMID: 38665060